According to the latest report by IMARC Group, titled “Sclerotherapy Market Report by Type (Ultrasound Sclerotherapy, Liquid Sclerotherapy, Foam Sclerotherapy), Agent (Detergents, Chemical Irritants, Osmotic Agents), and Region 2023-2028,” the global sclerotherapy market size reached US$ 1.15 Billion in 2022. Sclerotherapy is a medical procedure used to treat blood vessels or lymphatic vessel malformations, including varicose veins and spider veins. The treatment involves the injection of a solution, known as a sclerosing agent, directly into the affected vessel. This agent irritates the vessel's lining, causing it to collapse, stick together, and eventually be absorbed by the body. The blood flow then naturally reroutes through healthy veins. Sclerotherapy is considered a minimally invasive and effective method for dealing with cosmetic concerns related to unsightly veins, as well as alleviating symptoms like aching, swelling, or burning. It can be performed in a doctor's office and generally does not require anesthesia. The procedure usually takes less than an hour, and normal activities can typically be resumed shortly afterward. Compression stockings or bandages may be prescribed to aid healing, and multiple treatments might be necessary depending on the severity and number of veins treated. Side effects are typically mild and might include bruising, swelling, or temporary discoloration. Rare complications can include blood clots or inflammation, therefore it is essential to have the procedure performed by a qualified healthcare provider specializing in this treatment.
Global Sclerotherapy Market Trends:
The rising focus on aesthetic appeal and body image is leading to the increased demand for sclerotherapy for cosmetic purposes, particularly for treating spider veins, which represents one of the key factors driving the growth of the sclerotherapy market across the globe. The increase in conditions like varicose veins and spider veins, is facilitating the demand for sclerotherapy. This is primarily attributed to aging, obesity, and sedentary lifestyles, which are further boosting the growth of the market. The aging global population is more prone to venous disorders and represents a significant segment requiring sclerotherapy treatment, which is driving the market. The market is also driven by innovation in sclerosing agents and improved techniques which are making the procedure more efficient and less painful, thus attracting more patients. In line with this, the expansion of healthcare facilities, especially in emerging markets, is making sclerotherapy more accessible to a broader patient base which is fueling the growth of the market. In addition to this, favorable insurance coverage for treating venous disorders is reducing the financial burden on patients, which is making sclerotherapy a more attractive option, thus propelling the growth of the market. Apart from this, the increasing awareness and understanding of venous disorders and available treatments are leading more people to seek medical intervention which is creating a positive outlook for the market across the globe. Looking forward, the market value is projected to reach US$ 1.66 Billion by 2028, expanding at a CAGR of 6.10 % during 2023-2028.
- Based on the type, the market has been segmented into ultrasound sclerotherapy, liquid sclerotherapy, and foam sclerotherapy. Presently, liquid sclerotherapy holds the largest market share across the globe.
- On the basis of the agent, the market has been classified into detergents, chemical irritants, and osmotic agents. Currently, detergents are dominating the market across the globe.
- Based on the region, the market has been divided into North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Presently, North America holds the largest market share across the globe.
- The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include AngioDynamics, Boston Scientific Corporation, Chemische Fabrik Kreussler & Co. GmbH, Cook Medical, Inc., Medtronic PLC, Mylan N.V, Tianyu Chang’an Group, etc.
|Base Year of the Analysis
| Historical Period
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
||Ultrasound Sclerotherapy, Liquid Sclerotherapy, Foam Sclerotherapy
||Detergents, Chemical Irritants, Osmotic Agents
||Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||AngioDynamics, Boston Scientific Corporation, Chemische Fabrik Kreussler & Co. GmbH, Cook Medical, Inc., Medtronic PLC, Mylan N.V, Tianyu Chang’an Group, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800